15
Gastroenterol 2007;13:14-21.
3.
Glebe D, Urban S. Viral and cellular determinants involved in hepadnaviral entry.
World J Gastroenterol 2007;13:22-38.
4.
Ganem D, Prince AM. Hepatitis B infection: natural history and clinical
consequences. New England Journal of Medicine 2004;350:1118-1129.
5.
Beck J, Nassal M. Hepatitis B virus replication. World J Gastroenterol 2007;13(1):48-
64.
6.
Wang GH, Seeger C. Novel mechanism for reverse transcription in hepatitis B
viruses. J Virol 1993;67:6507-6512.
7.
Block TM, Guo H, Guo JT. Molecular virology of hepatitis B virus for clinicians. Clin
Liver Dis 2007;11:685-706.
8.
Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev 2000;64:51-
68.
9.
Schultz U, Grgacic E, Nassal M. Duck hepatitis B virus: an invaluable model system
for HBV infection. Adv Virus Res 2004;63:1-70.
10.
Schulze A, Gripon P, Urban S. Hepatitis B virus infection initiates with a large
surface protein-dependent binding to heparan sulfate proteoglycans. Hepatology
2007;46:1759-1768.
11.
Schulze A, Mills K, Weiss TS, Urban S. Hepatocyte polarization is essential for the
productive entry of the hepatitis B virus. Hepatology 2012;55:373-383.
12.
Urban S, Schulze A, Dandri M, Petersen J. The replication cycle of hepatitis B virus.
J Hepatol 2010;52:282-4.
13.
Urban S. New insights into hepatitis B and hepatitis delta virus entry. Future Virol
2008;3:253-264.
14.
Rabe B, Glebe D, Kann M. Lipid-mediated introduction of hepatitis B virus capsids
into nonsusceptible cells allows highly efficient replication and facilitates the study
of early infection events. J Virol 2006;80:5465-73.
15.
Kann M, Schmitz A, Rabe B. Intracellular transport of hepatitis B virus. World J
Gastroenterol 2007;13:39-47.
16.
Kann M, Sodeik B, Vlachou A, Gerlich WH, Helenius A. Phosphorylation-dependent
binding of hepatitis B virus core particles to the nuclear pore complex. J Cell Biol
1999;145:45-55.
17.
Köck J, Baumert TF, Delaney WE 4th, Blum HE, von Weizsäcker F. Inhibitory effect
of adefovir and lamivudine on the initiation of hepatitis B virus infection in primary
tupaia hepatocytes. Hepatology 2003; 38: 1410-1418.
18.
Newbold JE, Xin H, Tencza M, Sherman G, Dean J, Bowden S, Locarnini S.
The covalently closed duplex form of the hepadnavirus genome exists in situ
as a heterogeneous population of viral minichromosomes. Journal of Virology
1995;69:3350-3357.
19.
Summers J, Mason WS. Residual integrated viral DNA after hepadnavirus
clearance by nucleoside analog therapy. Proc Natl Acad Sci USA 2004;101:638-40.
20.
Zoulim F. New insight on hepatitis B virus persistence from the study of
intrahepatic viral cccDNA. J Hepatol 2005;42:302-8.
21.
Bock CT, Schwinn S, Locarnini S, et al. Structural organization of the hepatitis B
virus minichromosome. J Mol Biol 2001;307:183-96.
22.
Schadler S, Hildt E. HBV life cycle: Entry and morphogenesis. Viruses 2009;1:185-
209.
23.
Dandri M, Petersen J. HBV virology. In Mauss S, Berg T, Rockstroh J, Sarrazin C,
Wedemeyer H (eds). Hepatology A Clinical Textbook. 3rd ed. Germany: Flying
Hepatit B Virüsünün Moleküler Virolojisi
